Healthcare Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Industry Today.

Press releases published on September 9, 2026

Sep. 9, 2026

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Indeterminate GlobeNewswire

Sep. 9, 2026

Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Indeterminate GlobeNewswire

Sep. 9, 2026

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

LifeStance Health Group Announces Launch of Secondary Public Offering

Indeterminate GlobeNewswire

Sep. 9, 2026

OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation

Indeterminate GlobeNewswire

Sep. 9, 2026

Invisible Balance Disorders Affect Millions

Indeterminate GlobeNewswire

Sep. 9, 2026

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

Indeterminate GlobeNewswire

Sep. 9, 2026

RadNet to Host Free Prostate Cancer Webinar on September 19, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes

Indeterminate GlobeNewswire

Sep. 9, 2026

Athernal Bio Secures Innovate UK Grant to Advance Cancer Interception in High-Risk Leukaemia

Indeterminate GlobeNewswire

Sep. 9, 2026

Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide

Indeterminate GlobeNewswire

Sep. 9, 2026

Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers

Indeterminate GlobeNewswire

Sep. 9, 2026

Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial

Indeterminate GlobeNewswire

Sep. 9, 2026

ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury

Indeterminate GlobeNewswire

Sep. 9, 2026

Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Allegro’s Hydrocelin significantly improves knee osteoarthritis pain and function in clinical trial

Indeterminate GlobeNewswire

Sep. 9, 2026

Allegro rapporteert bemoedigende klinische resultaten met gepatenteerde injecteerbare nanotechnologie voor knieartrose

Indeterminate GlobeNewswire